Thomas McDonnell

5PUBLICATIONS
23CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Clinical chemistry (incl. diagnostics)Medical infection agents (incl. prions)HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 04, 2026
Controlling cardiovascular risk factors reduces progression of atherosclerosis in a multiethnic cohort of patients with lupus.

|May 30, 2024
Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?

Ömer Uludağ, Suzan Çinar, Thomas McDonnell

|Dec 23, 2022
Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis.

Meredyth G Ll Wilkinson, Dale Moulding, Thomas C R McDonnell

|Aug 25, 2022
Antibodies to FXa and thrombin in patients with SLE differentially regulate C3 and C5 cleavage.

Thomas McDonnell, Raj Amarnani, Carina Spicer

|May 26, 2019
Domain I of β2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation.

A Albay, B Artim-Esen, C Pericleous

Pageof 1

Frequent Collaborators

3 joint publications

Chris Wincup

2 joint publications

Bahar Artim Esen

2 joint publications

Anisur Rahman

1 joint publications

Meredyth G Ll Wilkinson